Empayug L 25/5 Tablet

Empayug L 25/5 Tablet is a prescription diabetes medicine that contains empagliflozin 25 mg and linagliptin 5 mg in each tablet. It combines an SGLT2 inhibitor with a DPP-4 inhibitor to help lower blood sugar in adults with type 2 diabetes. Empayug L 25/5 Tablet is used along with diet and exercise to improve glucose control, and it may also be chosen when one medicine alone is not enough.

How it works: In this tablet, empagliflozin helps the kidneys remove extra sugar through the urine, while linagliptin helps the body release more insulin after meals and lowers sugar made by the liver. Together, Empayug L 25/5 Tablet works to reduce blood glucose throughout the day.

Empayug L 25/5 Tablet is a higher-strength combination tablet, with empagliflozin at 25 mg, which is the upper usual dose for this ingredient, plus linagliptin 5 mg. Because of that, it is generally suited for adults who have already been assessed by a doctor and need stronger blood sugar lowering rather than a lower-strength starting option. A clinician may choose Empayug L 25/5 Tablet when the goal is to simplify treatment into one tablet while providing a more intensive effect.

• Type 2 diabetes mellitus
• Blood sugar control along with diet and exercise
• Add-on treatment when one diabetes medicine is not enough
• Convenient combination therapy in one tablet

• Swallow Empayug L 25/5 Tablet whole with water; do not crush, split, or chew unless your doctor specifically says otherwise.
• Take it exactly as prescribed at the same time each day.
• This tablet can usually be taken with or without food.
• Drink enough fluids, especially if you are active, sweating, or have vomiting or diarrhea.
• If you miss a dose, take it when you remember unless it is almost time for the next dose; do not double up.
• Check your blood sugar as directed by your doctor while using this tablet.

Each Empayug L 25/5 Tablet provides empagliflozin 25 mg plus linagliptin 5 mg per tablet, which is a full-strength combination for many adults with type 2 diabetes. It may be taken once daily if prescribed, but the exact schedule and whether it is appropriate for you are determined by your doctor based on your blood sugar, kidney function, and other medicines. Do not take more than the prescribed dose in a day.

Do not change your dose or stop the medicine without speaking to your doctor.

Common side effects of Empagliflozin + Linagliptin may include:

• Urinary tract infection
• More frequent urination
• Thirst or mild dehydration
• Nasal congestion or sore throat
• Headache
• Low blood sugar when used with insulin or sulfonylureas
• Dizziness, which may be more noticeable at this higher-strength combination

• Empayug L 25/5 Tablet is for type 2 diabetes only and is not used for type 1 diabetes or diabetic ketoacidosis.
• Because it contains the higher 25 mg empagliflozin strength, your doctor may be extra careful if you have kidney problems or a history of dehydration.
• This medicine can increase urination, so dehydration is a concern in hot weather, heavy exercise, vomiting, or diarrhea.
• Alcohol can raise the risk of low blood sugar or dehydration, especially if you also take insulin or a sulfonylurea.
• Tell your doctor if you have heart disease, low blood pressure, recurrent urinary infections, or genital yeast infections.
• Use caution when driving or operating machinery if you feel dizzy or weak.
• If you take insulin or another diabetes medicine, your doctor may need to adjust those doses to reduce low blood sugar risk.

• Insulin and sulfonylureas may increase the risk of low blood sugar when combined with Empayug L 25/5 Tablet.
• Diuretics can raise the risk of dehydration and low blood pressure.
• Rifampin and some other medicines may affect linagliptin levels.
• Other diabetes medicines may need dose adjustment to avoid hypoglycemia.
• Tell your doctor about all prescription drugs, over-the-counter medicines, and supplements before starting this tablet.

Store Empayug L 25/5 Tablet in its original strip/box at room temperature, away from moisture, heat, and direct light.